Related Experiment Video

Updated: Jun 13, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Genetics and cardiac channelopathies

Oscar Campuzano1, Pedro Beltrán-Alvarez, Anna Iglesias

  • 1Cardiovascular Genetics Center, UdG-IdIBGi, University of Girona, Girona, Spain.

Genetics in Medicine : Official Journal of the American College of Medical Genetics
|April 14, 2010
PubMed

Insights

Sudden cardiac death (SCD) is a leading cause of mortality. Genetic testing improves diagnosis of inherited cardiac diseases, aiding risk assessment and prevention strategies for affected families.

Area of Science:

  • Cardiology
  • Genetics
  • Pathology

Background:

  • Sudden cardiac death (SCD) is a significant cause of mortality in industrialized nations, often exceeding deaths from AIDS, lung cancer, breast cancer, and stroke combined.
  • Autopsies are primary diagnostic tools for SCD, but a substantial number of cases remain unexplained, termed arrhythmogenic or natural sudden deaths.
  • In young individuals, up to 50% of SCD cases are the first and only manifestation of an undetected inherited cardiac disease.

Purpose of the Study:

  • To review recent advancements in understanding the genetic basis of sudden cardiac death and inherited cardiopathies.
  • To highlight the role of genetic testing in improving the diagnosis and management of inherited cardiac conditions.
  • To emphasize the importance of genetic expertise in risk stratification and prevention strategies for sudden cardiac death.

Main Methods:

  • Review of recent scientific literature focusing on genetic investigations of sudden cardiac death.
  • Analysis of progress in understanding the genetic underpinnings of inherited cardiopathies.
  • Synthesis of information on the application of genetic testing in clinical practice for sudden cardiac death.

Main Results:

  • Significant progress has been made in understanding the genetics of sudden cardiac death over the past two decades.
  • Genetic testing is increasingly integrated into clinical practice for diagnosing inherited cardiac diseases.
  • Genetic information empowers probands and families to make informed decisions about care and risk.

Conclusions:

  • Genetic investigations are crucial for diagnosing certain forms of inherited cardiac diseases that cause sudden cardiac death.
  • Genetic technology and expertise are essential for developing effective prevention strategies.
  • Improved understanding of genetic factors in cardiopathies enhances diagnostic capabilities and patient management for sudden cardiac death.

More Related Videos

Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry11:32

Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry

Published on: September 28, 2016

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes11:33

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Published on: March 12, 2013

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...